An Open-Label Crossover Study To Evaluate Potential Pharmacokinetic Interactions between Oral Oseltamivir and Intravenous Zanamivir in Healthy Thai Adults

There is no parenteral formulation of the neuraminidase inhibitor oseltamivir, the most widely used anti-influenza virus drug. Oseltamivir resistance is an increasing problem. Zanamivir is effective against the most prevalent oseltamivir-resistant influenza viruses. A parenteral formulation of zanam...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pukrittayakamee, Sasithon, Jittamala, Podjanee, Stepniewska, Kasia, Lindegardh, Niklas, Chueasuwanchai, Sunee, Leowattana, Wattana, Phakdeeraj, Aphiradee, Permpunpanich, Sutatip, Hanpithakpong, Warunee, Pan-Ngum, Wirichada, Fukuda, Caroline, Panapipat, Salwaluk, Singhasivanon, Pratap, White, Nicholas J., Day, Nicholas P. J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2011
Gaiak:
Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165358/
https://ncbi.nlm.nih.gov/pubmed/21690287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00159-11
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak